Id: acc3538
Group: 2sens
Protein: PDK4
Gene Symbol: PDK4
Protein Id: Q16654
Protein Name: PDK4_HUMAN
PTM: ubiquitination
Site: unclear
Site Sequence:
Disease Category: Immune system diseases
Disease: Colitis
Disease Subtype: Acute Severe Ulcerative Colitis
Disease Cellline:
Disease Info:
Drug: Cyclosporine A (CsA)
Drug Info: Cyclosporine A (CsA) is an immunosuppressive drug often used to prevent organ - rejection in transplant patients.
Effect: modulate
Effect Info: "Cyclosporine inhibits the ubiquitination of PDK4 by downregulating SIRT6, enhances glycolysis, and regulates neutrophil function to alleviate ASUC."
Note:
Score: 4.0
Pubmed(PMID): 33634990
Sentence Index:
Sentence:

Sequence & Structure:

MKAARFVLRSAGSLNGAGLVPREVEHFSRYSPSPLSMKQLLDFGSENACERTSFAFLRQELPVRLANILKEIDILPTQLVNTSSVQLVKSWYIQSLMDLVEFHEKSPDDQKALSDFVDTLIKVRNRHHNVVPTMAQGIIEYKDACTVDPVTNQNLQYFLDRFYMNRISTRMLMNQHILIFSDSQTGNPSHIGSIDPNCDVVAVVQDAFECSRMLCDQYYLSSPELKLTQVNGKFPDQPIHIVYVPSHLHHMLFELFKNAMRATVEHQENQPSLTPIEVIVVLGKEDLTIKISDRGGGVPLRIIDRLFSYTYSTAPTPVMDNSRNAPLAGFGYGLPISRLYAKYFQGDLNLYSLSGYGTDAIIYLKALSSESIEKLPVFNKSAFKHYQMSSEADDWCIPSREPKNLAKEVAM

Select PDB:

Known Drugs:

source: Multi-Sources

(see table)

Target Drug name MOA Phase Status Disease Source
PDK4 SODIUM DICHLOROACETATE Pyruvate dehydrogenase kinase inhibitor 3 Completed lactic acidosis ClinicalTrials
PDK4 SODIUM DICHLOROACETATE Pyruvate dehydrogenase kinase inhibitor 3 Active, not recruiting pyruvate dehydrogenase deficiency ClinicalTrials
PDK4 SODIUM DICHLOROACETATE Pyruvate dehydrogenase kinase inhibitor 2 Completed head and neck squamous cell carcinoma ClinicalTrials
PDK4 SODIUM DICHLOROACETATE Pyruvate dehydrogenase kinase inhibitor 2 Recruiting glioblastoma multiforme ClinicalTrials
PDK4 SODIUM DICHLOROACETATE Pyruvate dehydrogenase kinase inhibitor 2 Completed glioblastoma multiforme ClinicalTrials
PDK4 SODIUM DICHLOROACETATE Pyruvate dehydrogenase kinase inhibitor 2 Completed heart disease ClinicalTrials
PDK4 SODIUM DICHLOROACETATE Pyruvate dehydrogenase kinase inhibitor 2 Completed lactic acidosis ClinicalTrials
PDK4 SODIUM DICHLOROACETATE Pyruvate dehydrogenase kinase inhibitor 2 Terminated breast cancer ClinicalTrials
PDK4 SODIUM DICHLOROACETATE Pyruvate dehydrogenase kinase inhibitor 2 Terminated lung cancer ClinicalTrials
PDK4 SODIUM DICHLOROACETATE Pyruvate dehydrogenase kinase inhibitor 1 Withdrawn glioblastoma multiforme ClinicalTrials
PDK4 SODIUM DICHLOROACETATE Pyruvate dehydrogenase kinase inhibitor 1 Completed pulmonary arterial hypertension ClinicalTrials

Note: Only show clinically investigational or approved drugs with protein targets.

Protein Tractability:

source: Open Targets
Small molecule
Antibody
PROTAC
Other modalities
Approved Drug
Advanced Clinical
Phase 1 Clinical
Structure with Ligand
High-Quality Ligand
High-Quality Pocket
Med-Quality Pocket
Druggable Family
Approved Drug
Advanced Clinical
Phase 1 Clinical
UniProt loc high conf
GO CC high conf
UniProt loc med conf
UniProt SigP or TMHMM
GO CC med conf
Human Protein Atlas loc
Approved Drug
Advanced Clinical
Phase 1 Clinical
Literature
UniProt Ubiquitination
Database Ubiquitination
Half-life Data
Small Molecule Binder
Approved Drug
Advanced Clinical
Phase 1 Clinical

PTM Intensity:

source: CPTAC

No data.

PTM-Disease Association:

source: PTMD

No data.

PTM-Drug Perturbation Response:

source: DecryptM

No data.

Function score:

source: funscoR

No data.

Cross Links: